Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Confirmatory Phase 3 study of CardiAMP autologous cell therapy for the treatment of patients with ischemic heart failure

Next Previous
Search
Trial Profile

Confirmatory Phase 3 study of CardiAMP autologous cell therapy for the treatment of patients with ischemic heart failure

Status: Recruiting
Phase of Trial: Phase III

Latest Information Update: 16 Apr 2025

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs CardiALLO cell therapy (Primary)
  • Indications Heart failure
  • Focus Registrational; Therapeutic Use
  • Acronyms CardiAMP Heart Failure Trial II; CardiAMP HF II
  • Sponsors BioCardia

    • Most Recent Events

    • 11 Apr 2025 According to a BioCardia media release, Dr. Arshed Quyyumi, serve as principal investigator
    • 11 Apr 2025 According to a BioCardia media release, Emory University School of Medicine in Atlanta Georgia is now enrolling patients with ischemic heart failure in this trial. Emory University joins esteemed clinical sites throughout the United States participating in the study, this collaboration will assist the Company on many levels, including their anticipated strong support in accelerating patient enrollment in the CardiAMP HF II trial towards its target completion in 2027.
    • 17 Dec 2024 According to a BioCardia media release, the company expects five actively enrolling world class centers in the CardiAMP Heart Failure II Trial by the end of the first quarter of 2025.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top